Lactobacillus reuteri-an old acquaintance takes on a new task in colorectal tumor surveillance
- PMID: 35167822
- DOI: 10.1016/j.ccell.2022.01.014
Lactobacillus reuteri-an old acquaintance takes on a new task in colorectal tumor surveillance
Abstract
In this issue of Cancer Cell, Bell et al. identify the commensal bacterium Lactobacillus reuteri and its major metabolite reuterin as an important gatekeeper and promising target in colorectal cancerogenesis. They decipher a metabolic interplay in which L. reuteri is suppressed by metabolites from dysplastic intestinal epithelial cells which in turn are highly sensitive to the oxidative effects of the electrophile reuterin.
Copyright © 2022. Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests C.W. declares no competing interests. A.R.M. is receiving research support under the framework of the Christian Doppler Research Society from AbbVie and Takeda.
Comment on
-
Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance.Cancer Cell. 2022 Feb 14;40(2):185-200.e6. doi: 10.1016/j.ccell.2021.12.001. Epub 2021 Dec 23. Cancer Cell. 2022. PMID: 34951957 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical